Jul. 17 at 5:42 AM
$PMI $PMI 🫀🚀 Artificial heart innovator with a commercial-stage product addressing advanced heart failure. Revenue growth has been strong, the company continues executing strategic initiatives, and recent SEC filings signal active corporate progress. Tiny market cap + medical device catalyst potential = asymmetric upside. High risk, but if execution continues, this one could rerate quickly. #MedTech #MicroCap #HeartHealth